Posted May 15, 2014

FDA Warns Consumers Not To Buy Or Use Weight Loss Supplement

On May 12, 2014, the FDA warned consumers not to buy or use weight loss supplement Asset Bee Pollen because it was found to contain sibutramine.

Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.

Asset Bee Pollen was sold in some retail stores and on various websites, includingwww.assetcapsules4u.com.

Consumers who have purchased this supplement should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.

(See ConsumerLab.com's Review of Weight Loss Supplements for tests of related products.)

See Related Warnings:

Two Weight Loss Supplements Found To Contain Drug

Weight Loss Supplement Contains Undeclared Drug

Weight Loss Supplement Recall Expanded to Include Additional Products

Weight Loss Supplement Containing Drug Recalled

FDA Warns Consumers Of Weight Loss Supplement Containing Undeclared Drug

To read the FDA's warning, use the link below.